Policy & Medicine

CBO Simulates the Elijah E. Cummings Lower Drug Costs Now Act

Thomas Sullivan Sep 27, 2021 0

The Congressional Budget Office (CBO) recently released a Simulation Model of New Drug Development that mimicked the Elijah E. Cummings Lower Drug Costs Now Act (HR 3) introduced in the 2019-2020 Congressional session. Under the simulation, CBO estimated that it was likely that between 21 and 59 fewer drugs would be brought to market over the next…

Policy and Medicine Compliance Update — September 2021…

Thomas Sullivan Sep 11, 2021 0

When Money and Doritos Don’t Suffice – The…

Thomas Sullivan Oct 12, 2019 0

CBO Simulates the Elijah E. Cummings Lower Drug Costs Now Act

The Congressional Budget Office (CBO) recently released a Simulation Model of New Drug Development that mimicked the Elijah E. Cummings Lower Drug Costs Now Act (HR 3) introduced in the 2019-2020…

OPDP Sends Third Untitled Letter of the Year to Eton…

On August 9, 2021, the United States Food and Drug Administration (FDA) Office of Prescription Drug Promotion (OPDP) sent its third untitled letter of the year to Eton Pharmaceuticals over sponsored…

FDA Reconsidering the Need for Mandatory Opioid Prescriber…

Recently, the United States Food and Drug Administration (FDA) announced a public workshop to discuss mandatory prescriber education for opioids, reconsidering the need for mandatory opioid prescriber…

Sutter Health Reaches $90 Million Settlement Over Alleged False…

On August 30, 2021, the United States Department of Justice announced that Sutter Health, a California-based health care provider, agreed to pay $90 million to resolve allegations that the company and…

Fifth Circuit Court of Appeals Allows Government to Dismiss FCA…

Earlier this summer, a three-judge panel of the the United States Court of Appeals for the Fifth Circuit found in favor of the government and dismissed qui tam cases brought by Health Choice Alliance…

Telemedicine Fraud Scheme Results in Civil and Criminal…

On August 24, 2021, the United States Department of Justice announced civil and criminal enforcement actions against several medical practitioners for signing off on illegitimate orders for medical…

Alternative Drug Pricing Legislation Introduced by Moderate…

Centrist Democrats in the United States House of Representatives are working on introducing an alternate approach to drug pricing legislation than what is outlined in the wide-ranging H.R. 3 bill.…

CEO and CFO of SpineFrontier Charged in Bribery and Money…

On September 7, 2021, Kingsley R. Chin, MD, CEO of SpineFrontier, Inc.; Aditya Humad, CFO of SpineFrontier, Inc.; and SpineFrontier, Inc., were arrested and indicted on one count of conspiracy to…

Minnesota Updates Its Gift Ban to Include Certain Pharmacists

Earlier this year, Minnesota quietly updated its gift ban statute to include certain pharmacists. According to the new statute, pharmacists are considered practitioners if they prescribe…

Biden Administration Announces Drug Pricing Plan

On September 9, 2021, the United States Department of Health and Human Services (HHS) issued its Comprehensive Plan for Addressing High Drug Prices, a report in response to President Joe Biden’s…

Amended Complaint Filed in Abbott Labs Anti-Kickback Case

On August 19, 2021, Everest Principals filed an amended complaint on behalf of the United States government and several states (including California, Florida, Maryland, New York, Texas, and Virginia)…

Policy and Medicine Compliance Update — September 2021…

Policy and Medicine Compliance Update is our monthly compliance publication designed to help compliance professionals go in depth in issues and stay up to date on the latest trends. We encourage you…